Health Effects of Consuming Olive Pomace Oil
ORUJOSALUD-1
Assessment of the Health Effects of Olive Pomace Oil in Healthy and at Risk Consumers
1 other identifier
interventional
64
1 country
1
Brief Summary
Healthy and at risk (hypercholesterolemic) subjects consumed during 4 weeks 45 g/d of either olive pomace oil (OPO) or high oleic acid sunflower oil (HOSO) as the only dietary fat in a randomized, crossover trial. The effects on blood lipids, glucose homeostasis, endothelial function, inflammatory cytokines, oxidative stress biomarkers and anthropometry were measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Apr 2018
Shorter than P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 13, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 13, 2018
CompletedFirst Submitted
Initial submission to the registry
August 4, 2021
CompletedFirst Posted
Study publicly available on registry
August 9, 2021
CompletedAugust 16, 2021
August 1, 2021
3 months
August 4, 2021
August 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood lipids
Changes on total or LDL-cholesterol levels or triglycerides in at risk (hypercholesterolemic) subjects. No effect on blood lipids expected in healthy (normocholesterolemic ) volunteers
4 weeks
Secondary Outcomes (5)
Endothelial function
4 weeks
Blood pressure
4 weeks
Glucose homeostasis
4 weeks
Inflammation
4 weeks
Oxidative status
4 weeks
Study Arms (2)
Olive pomace oil
EXPERIMENTALIntake of 45 g/d of olive pomace oil as the only source of oil in the diet
High-oleic sunflower oil
ACTIVE COMPARATORIntake of 45 g/d of high-oleic sunflower oil as the only source of oil in the diet
Interventions
Volunteers consumed during 4 weeks 45 g/d of olive pomace oil as the only source of dietary fat, used for cooking, salad dressing, toasts, etc.
Volunteers consumed during 4 weeks 45 g/d of oleic acid-rich sunflower oil as the only source of dietary fat, used for cooking, salad dressing, toasts, etc.
Eligibility Criteria
You may qualify if:
- Healthy volunteers (Total cholesterol \< 200 mg/dL; LDL-cholesterol \< 135 mg/dL)
- Hypercholesterolemic volunteers (Total cholesterol 200-300 mg/dL; LDL-cholesterol 135-175 mg/dL)
You may not qualify if:
- BMI \> 30 Kg/m2
- Smokers
- Vegetarians
- Pregnant women
- Medication/consumption of vitamins, dietary supplements
- On antibiotic treatment 3 months before starting the study
- Digestive disorders/pathologies (gastric ulcer, Chron's disease, inflammatory bowel syndrome, etc.)
- Food allergies/intolerances
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto de Ciencia y Tecnología de Alimentos y Nutrición
Madrid, 28040, Spain
Related Publications (1)
Gonzalez-Ramila S, Sarria B, Seguido MA, Garcia-Cordero J, Mateos R, Bravo L. Olive pomace oil can improve blood lipid profile: a randomized, blind, crossover, controlled clinical trial in healthy and at-risk volunteers. Eur J Nutr. 2023 Mar;62(2):589-603. doi: 10.1007/s00394-022-03001-y. Epub 2022 Sep 24.
PMID: 36153442DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raquel Mateos, Dr
ICTAN-CSIC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Oils were provided in unlabelled bottles (only differed in the colors of stoppers)
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 4, 2021
First Posted
August 9, 2021
Study Start
April 2, 2018
Primary Completion
July 13, 2018
Study Completion
July 13, 2018
Last Updated
August 16, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share